Factors affecting parametrial involvement in cervical cancer patients with tumor size ≤4 cm and selection of low-risk patient group

被引:1
作者
Akilli, Huseyin [1 ]
Tohma, Yusuf Aytac [1 ]
Gunakan, Emre [1 ]
Kucukyildiz, Irem [2 ]
Tunc, Mehmet [3 ]
Haberal, Nihan Reyhan [4 ]
Ayhan, Ali [1 ]
机构
[1] Baskent Univ, Dept Obstet & Gynecol, Fac Med, Ankara, Turkey
[2] Sivas Cumhuriyet Univ, Dept Obstet & Gynecol, Fac Med, Sivas, Turkey
[3] Ankara Kecioren Training & Res Hosp, Clin Obstet & Gynecol, Ankara, Turkey
[4] Baskent Univ, Dept Pathol, Fac Med, Ankara, Turkey
关键词
Low-risk cervical cancer; parametrial invasion; less radical surgery; RADICAL SURGERY; SQUAMOUS CANCER; CARCINOMA; HYSTERECTOMY; CONIZATION; LYMPHADENECTOMY; TRACHELECTOMY; MANAGEMENT; WOMEN;
D O I
10.4274/jtgga.galenos.2020.2020.0153
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The primary aim of this study was to evaluate the factors affecting parametrial involvement in cervical cancer patients with tumor size <= 4 cm and selection of the low-risk patient group based on long-term oncologic outcomes. Material and Methods: Cervical cancer patients operated in the gynecologic oncology division between 2007 and 2013 were retrospectively evaluated. One-hundred and sixty-eight patients with tumor size <= 4 cm were identified. Of these, 159 (86.8%) underwent radical hysterectomy plus pelvic-para- aortic lymphadenectomy and nine (13.2%) underwent fertility-sparing surgery [radical trachelectomy (n= 7); large conization (n=2)]. Factors affecting parametrial invasion, including lymphovascular space invasion (LVSI), deep stromal invasion (DSI), lymph node metastases, and tumor size, were evaluated. Statistical analyses were performed using SPSS 23.0 (IBM Corp., Armonk, NY, USA). Results: Median age was 49.5 years and median tumor size was 2.5 cm ( 0.45-4 cm). In both univariate and multivariate analyses, the risk of parametrial involvement was increased with LVSI with a hazard ratio (HR) of 3.45 [95% confidence interval (CI): 1.1-10.8] and DSI with a HR of 4.1 (95% CI: 1.18-14.8), while tumor size of <= 2 cm was only significant in univariate analyses. Furthermore, 26 early-stage patients were identified with low-risk factors and they had no parametrial involvement, lymph node metastases, recurrence, or death from disease over 77 months. Conclusion: Parametrial involvement in low-risk cervical cancer is very rare and less radical procedures may be safe in these patients.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 50 条
  • [21] Tumor Size, an Additional Prognostic Factor to Include in Low-Risk Endometrial Cancer: Results of a French Multicenter Study
    Canlorbe, Geoffroy
    Bendifallah, Sofiane
    Laas, Enora
    Raimond, Emilie
    Graesslin, Olivier
    Hudry, Delphine
    Coutant, Charles
    Touboul, Cyril
    Bleu, Geraldine
    Collinet, Pierre
    Cortez, Annie
    Darai, Emile
    Ballester, Marcos
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (01) : 171 - 177
  • [22] Incidence of Lymph Node Metastases in Women With Low-Risk Early Cervical Cancer (&lt;2 cm) Without Lymph-Vascular Invasion
    Minig, Lucas
    Fagotti, Anna
    Scambia, Giovanni
    Salvo, Gloria
    Patrono, Maria Guadalupe
    Haidopoulos, Dimitrios
    Zapardiel, Ignacio
    Domingo, Santiago
    Sotiropoulou, Maria
    Chisholm, Gary
    Ramirez, Pedro T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (04) : 788 - 793
  • [23] Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study
    Brooks, Joanna Veazey
    Ellis, Shellie D.
    Morrow, Emily
    Kimminau, Kim S.
    Thrasher, J. Brantley
    AMERICAN JOURNAL OF MENS HEALTH, 2018, 12 (05) : 1719 - 1727
  • [24] Stage IB1 cervical cancer patients with an MRI-measured tumor size ≤ 2 cm might be candidates for less-radical surgery
    Kodama, J.
    Fukushima, C.
    Kusumoto, T.
    Nakamura, K.
    Seki, N.
    Hongo, A.
    Hiramatsu, Y.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (01) : 39 - 41
  • [25] Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study
    Sozzi, Giulio
    Uccella, Stefano
    Berretta, Roberto
    Petrillo, Marco
    Fanfani, Francesco
    Monterossi, Giorgia
    Ghizzoni, Viola
    Frusca, Tiziana
    Ghezzi, Fabio
    Chiantera, Vito
    Scambia, Giovanni
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (04) : 684 - 691
  • [26] Low-Risk Human Papillomavirus Types in Cervical Intraepithelial Neoplasia 2-3 and in Invasive Cervical Cancer Patients
    Siegler, Efraim
    Reichman, Yael
    Kugelman, Nir
    Mackuli, Lena
    Lavie, Ofer
    Ostrovsky, Ludmila
    Shaked-Mishan, Pninint
    Segev, Yakir
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2019, 23 (04) : 248 - 252
  • [27] The Identification of Intraoperative Risk Factors Can Reduce, but Not Exclude, the Need for Completion Thyroidectomy in Low-Risk Papillary Thyroid Cancer Patients
    Craig, Steven J.
    Bysice, Andrew M.
    Nakoneshny, Steven C.
    Pasieka, Janice L.
    Chandarana, Shamir P.
    THYROID, 2020, 30 (02) : 222 - 228
  • [28] Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification
    Bae, Bong Kyung
    Cho, Won Kyung
    Kim, Byoung-Gie
    Choi, Chel Hun
    Kim, Tae-Joong
    Lee, Yoo-Young
    Lee, Jeong-Won
    Park, Won
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (12) : 1524 - 1530
  • [29] Use of preoperative clinicopathologic characteristics to identify patients with low-risk cervical cancer suitable for Piver class II radical hysterectomy
    Xiong, Ying
    Liu, Ji-hong
    Zheng, Min
    Cao, Li-ping
    Liang, Li-zhi
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2013, 122 (01) : 52 - 56
  • [30] Risk factors for tumor enlargement in low-risk papillary thyroid microcarcinoma patients: a systematic review and meta-analysis
    Luo, Nengwen
    Shi, Xinlong
    Xia, Yu
    Gao, Luying
    Li, Xiaoyi
    Jiang, Yuxin
    ENDOCRINE, 2024, 85 (03) : 1041 - 1049